---
title: 'Association between 21-gene-assay and detection of disseminated tumor cells
  in patients with early breast cancer: results from the IRMA trial'
date: '2023-08-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37556015/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230809180842&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: We therefore confirm that a high genomic risk is associated
  with tumor cell dissemination into the BM. Further trials are needed to investigate
  whether therapeutic decisions could be further individualized by combining DTC-status
  and prognostic gene signature ...'
disable_comments: true
---
CONCLUSION: We therefore confirm that a high genomic risk is associated with tumor cell dissemination into the BM. Further trials are needed to investigate whether therapeutic decisions could be further individualized by combining DTC-status and prognostic gene signature ...